Fungizone and Myelitis transverse - a phase IV clinical study of FDA data
Myelitis transverse is reported only by a few people who take Fungizone.
The phase IV clinical study analyzes which people take Fungizone and have Myelitis transverse. It is created by eHealthMe based on reports of 4,105 people who have side effects while taking Fungizone from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,105 people reported to have side effects when taking Fungizone.
Among them, 2 people (0.05%) have Myelitis transverse.
What is Fungizone?
Fungizone has active ingredients of amphotericin b. eHealthMe is studying from 4,110 Fungizone users for its effectiveness, alternative drugs and more.
What is Myelitis transverse?
Myelitis transverse (a neurological condition consisting of an inflammatory process of the spinal cord) is found to be associated with 654 drugs and 291 conditions by eHealthMe.
Number of Fungizone and Myelitis transverse reports submitted per year:
Gender of people who have Myelitis transverse when taking Fungizone *:
- female: 0.0 %
- male: 100 %
Age of people who have Myelitis transverse when taking Fungizone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 100 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Fungizone and have Myelitis transverse?Check whether Myelitis transverse is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Myelitis transverse and when was it recovered:
Expand to all the drugs that have ingredients of amphotericin b:
Alternative drugs to, pros and cons of Fungizone:
- Fungizone (4,110 reports)
Common Fungizone side effects:
- Fever: 434 reports
- Thrombocytopenia (decrease of platelets in blood): 359 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 237 reports
- Pneumonia: 193 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 191 reports
- Diarrhea: 172 reports
- Rashes (redness): 150 reports
Browse all side effects of Fungizone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Myelitis transverse treatments and more:
- Myelitis transverse (1,863 reports)
COVID vaccines that are related to Myelitis transverse:
- Myelitis transverse in Moderna COVID Vaccine
- Myelitis transverse in Pfizer BioNTech Covid Vaccine
- Myelitis transverse in Johnson and Johnson Covid Vaccine
Common drugs associated with Myelitis transverse:
- Methotrexate: 146 reports
- Enbrel: 108 reports
All the drugs that are associated with Myelitis transverse:
- Myelitis transverse (654 drugs)
Common conditions associated with Myelitis transverse:
- Multiple sclerosis: 217 reports
All the conditions that are associated with Myelitis transverse:
- Myelitis transverse (291 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amphotericin b (the active ingredients of Fungizone) and Fungizone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Catapres vs. Capoten - 5 seconds ago
- Arzerra and Joint Pain - 5 seconds ago
- Estrace and Amantadine Hydrochloride drug interaction - 14 seconds ago
- Zetia and Withdrawal Syndrome - 18 seconds ago
- Hydroxyzine Hydrochloride vs. Carisoprodol - 27 seconds ago
- Asa and Obstructive Uropathy - 34 seconds ago
- Vanceril and Sleep Apnea Syndrome - 35 seconds ago
- Sucralfate and Kisqali drug interaction - 35 seconds ago
- Micardis and Empliciti drug interaction - 48 seconds ago
- Adderall 10 and Erection Problems - 54 seconds ago